This article is more than 5 years old. Information may no longer be current.

8 important updates for World Lung Cancer Day

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Today marks World Lung Cancer Day.

The observance — intended to raise awareness about the impact of lung cancer — is held every year on Aug. 1.

Lung cancer remains the leading cause of death from cancer worldwide. An estimated 228,150 new cases will be diagnosed in the United States this year and more than 142,000 people will die of the disease, according to the American Cancer Society.

In conjunction with World Lung Cancer Day, HemOnc Today and Healio.com present eight important updates in treatment, research and screening.

1. More than 80% of patients with advanced lung cancer achieved stable disease after receiving investigational therapy of highly activated natural killer cells. Read more.

2. Patients undergoing radiation for non-small cell lung cancer at the time of a hurricane disaster declaration achieved shorter OS than patients who completed treatment under normal conditions. Read more.

3. Combining radiotherapy and pembrolizumab (Keytruda, Merck) appeared safe and induced promising responses among patients with advanced NSCLC. Read more.

Lung cancer remains the leading cause of death from cancer worldwide. An estimated 228,150 new cases will be diagnosed in the United States this year and more than 142,000 people will die of the disease, according to the American Cancer Society.

Source: Adobe Stock

4. HemOnc Today’s most recent Molecular Oncology column focused on precision medicine shortcomings for NSCLC. “This year’s ASCO Annual Meeting included several major successes that should translate to new molecular targets in advanced non-small cell lung cancer, but recent real-world evidence should lead us to take a hard look in the mirror and realize we’re failing to deliver on the promise of the treatments we already have,” Howard (Jack) West, MD, associate clinical professor of medical oncology at City of Hope Comprehensive Cancer Center, wrote in the column. Read more.

5. Reductions in lung cancer mortality with low-dose CT screening vs. chest X-ray among participants in the National Lung Screening Trial have been sustained over extended follow-up. Read more.

6. Higher doses of radiation to immune cells appeared associated with tumor progression and shorter OS among patients with stage III non-small cell lung cancer. Read more.

7. Race-specific modifications to U.S. Preventive Services Task Force lung cancer screening guidelines could reduce large disparities in sensitivity and specificity between African American and white smokers. Read more.

8. The use of expanded eligibility criteria would allow nearly twice as many people with NSCLC to participate in clinical trials. Read more.